Disruption of TBP-2 Ameliorates Insulin Sensitivity and Secretion Without Affecting Obesity

Overview

Journal Nat Commun

Specialty Biology

Date 2010 Dec 2

PMID 21119640

Citations 62

Authors

Eiji Yoshihara

Shimpei Fujimoto

Nobuya Inagaki

Katsuya Okawa

So Masaki

Junji Yodoi

Hiroshi Masutani

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by defects in both insulin sensitivity and glucose-stimulated insulin secretion (GSIS) and is often accompanied by obesity. In this study, we show that disruption of thioredoxin binding protein-2 (TBP-2, also called Txnip) in obese mice (ob/ob) dramatically improves hyperglycaemia and glucose intolerance, without affecting obesity or adipocytokine concentrations. TBP-2-deficient ob/ob mice exhibited enhanced insulin sensitivity with activated insulin receptor substrate-1/Akt signalling in skeletal muscle and GSIS in islets compared with ob/ob mice. The elevation of uncoupling protein-2 (UCP-2) expression in ob/ob islets was downregulated by TBP-2 deficiency. TBP-2 overexpression suppressed glucose-induced adenosine triphosphate production, Ca(2+) influx and GSIS. In β-cells, TBP-2 enhanced the expression level and transcriptional activity of UCP-2 by recruitment of peroxisome proliferator-activated receptor-γ co-activator-1α to the UCP-2 promoter. Thus, TBP-2 is a key regulatory molecule of both insulin sensitivity and GSIS in diabetes, raising the possibility that inhibition of TBP-2 may be a novel therapeutic approach for T2DM.

Citing Articles

Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes.

Yoshihara E Ann Transl Med. 2025; 12(6):121.

PMID: 39817230 PMC: 11729811. DOI: 10.21037/atm-24-129.

Heterogeneous enhancer states orchestrate β cell responses to metabolic stress.

Wang L, Wu J, Sramek M, Obayomi S, Gao P, Li Y Nat Commun. 2024; 15(1):9361.

PMID: 39472434 PMC: 11522703. DOI: 10.1038/s41467-024-53717-0.

Correlation between circulating advanced glycation end products and thioredoxin-interacting protein levels and renal fat content in type 2 diabetes mellitus patients.

Hua Y, Yin Z, Li M, Sun H, Shi B Diabetol Metab Syndr. 2024; 16(1):144.

PMID: 38951835 PMC: 11218298. DOI: 10.1186/s13098-024-01361-5.

Insights into the roles of inositol hexakisphosphate kinase 1 (IP6K1) in mammalian cellular processes.

Chakkour M, Greenberg M J Biol Chem. 2024; 300(4):107116.

PMID: 38403246 PMC: 11065760. DOI: 10.1016/j.jbc.2024.107116.

Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models.

Matsukawa T, Yagi T, Uchida T, Sakai M, Mitsushima M, Naganuma T JCI Insight. 2023; 8(17).

PMID: 37681411 PMC: 10544238. DOI: 10.1172/jci.insight.161282.

References

Lee K, Kang H, Jeon J, Kim E, Yoon S, Song H . VDUP1 is required for the development of natural killer cells. Immunity. 2005; 22(2):195-208. DOI: 10.1016/j.immuni.2004.12.012. View

Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, Yamada S . Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J. 2005; 20(1):121-3. DOI: 10.1096/fj.05-4439fje. View

Medvedev A, Robidoux J, Bai X, Cao W, Floering L, Daniel K . Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J Biol Chem. 2002; 277(45):42639-44. DOI: 10.1074/jbc.M208645200. View

MacDonald M . Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells. J Biol Chem. 2007; 282(9):6043-52. DOI: 10.1074/jbc.M606652200. View

Hirasawa T, Ohara T, Makino S . Genetic typing of the mouse ob mutation by PCR and restriction enzyme analysis. Exp Anim. 1997; 46(1):75-8. DOI: 10.1538/expanim.46.75. View

Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J . Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2009; 11(2):136-40. DOI: 10.1038/ni.1831. View

Anello M, Lupi R, Spampinato D, Piro S, Masini M, Boggi U . Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia. 2005; 48(2):282-9. DOI: 10.1007/s00125-004-1627-9. View

Nishinaka Y, Masutani H, Oka S, Matsuo Y, Yamaguchi Y, Nishio K . Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J Biol Chem. 2004; 279(36):37559-65. DOI: 10.1074/jbc.M405473200. View

Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J . Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes Dev. 2004; 18(3):278-89. PMC: 338281. DOI: 10.1101/gad.1152204. View

10.

Chen J, Hui S, Couto F, Mungrue I, Davis D, Attie A . Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J. 2008; 22(10):3581-94. PMC: 2537437. DOI: 10.1096/fj.08-111690. View

11.

Chutkow W, Birkenfeld A, Brown J, Lee H, Frederick D, Yoshioka J . Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes. 2010; 59(6):1424-34. PMC: 2874703. DOI: 10.2337/db09-1212. View

12.

Patwari P, Chutkow W, Cummings K, Verstraeten V, Lammerding J, Schreiter E . Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J Biol Chem. 2009; 284(37):24996-5003. PMC: 2757204. DOI: 10.1074/jbc.M109.018093. View

13.

Stoltzman C, Peterson C, Breen K, Muoio D, Billin A, Ayer D . Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proc Natl Acad Sci U S A. 2008; 105(19):6912-7. PMC: 2383952. DOI: 10.1073/pnas.0712199105. View

14.

Fujimoto S, Ishida H, Kato S, Okamoto Y, Tsuji K, Mizuno N . The novel insulinotropic mechanism of pimobendan: direct enhancement of the exocytotic process of insulin secretory granules by increased Ca2+ sensitivity in beta-cells. Endocrinology. 1998; 139(3):1133-40. DOI: 10.1210/endo.139.3.5771. View

15.

Yoshihara E, Chen Z, Matsuo Y, Masutani H, Yodoi J . Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling. Methods Enzymol. 2010; 474:67-82. DOI: 10.1016/S0076-6879(10)74005-2. View

16.

Hui S, Andres A, Miller A, Spann N, Potter D, Post N . Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci U S A. 2008; 105(10):3921-6. PMC: 2268825. DOI: 10.1073/pnas.0800293105. View

17.

Masson E, Koren S, Razik F, Goldberg H, Kwan E, Sheu L . High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice. Am J Physiol Endocrinol Metab. 2009; 296(6):E1251-61. PMC: 2981602. DOI: 10.1152/ajpendo.90619.2008. View

18.

Sreekumar R, Halvatsiotis P, Schimke J, Nair K . Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes. 2002; 51(6):1913-20. DOI: 10.2337/diabetes.51.6.1913. View

19.

Chutkow W, Patwari P, Yoshioka J, Lee R . Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production. J Biol Chem. 2007; 283(4):2397-406. DOI: 10.1074/jbc.M708169200. View

20.

Oberkofler H, Klein K, Felder T, Krempler F, Patsch W . Role of peroxisome proliferator-activated receptor-gamma coactivator-1alpha in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells. Endocrinology. 2005; 147(2):966-76. DOI: 10.1210/en.2005-0817. View